elected in Biological Technology

American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China

NEW YORK, July 21 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB ), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the cou...

Professor Wing Wong Elected to the National Academy of Sciences

aTyr Pharma Scientific Advisory Board Member Recognized for Development of Statistical Methods and Software SAN DIEGO, May 18 /PRNewswire/ -- Wing Hung Wong, Professor of Statistics and of Health Research & Policy at Stanford University has been elected to the US National Academy of Sci...

Dr. Thomas Werner Elected to Accera, Inc.'s Board of Directors

BROOMFIELD, Colo., March 24 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, announced today that Thomas Werner, Ph.D. has been elected to its board of directors. Since 2001, Dr. Werner has been a managing direct...

Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors

MIAMI, Nov. 26 /PRNewswire/ -- Thomas K. Equels, President and Managing Director of the Equels Law Firm, has been elected to the board of directors for Hemispherx BioPharma, Inc. (Amex: HEB ), a Philadelphia-based biopharmaceutical company engaged in the manufacture and clinical development of n...

Canary Foundation's Dr. Sanjiv Sam Gambhir Elected to the National Academies Institute of Medicine

SAN JOSE, Calif., Oct. 21 /PRNewswire/ -- Canary Foundation, a nonprofit organization that funds research in early cancer detection, announced that its Scientific Program Director, Dr. Sanjiv Sam Gambhir, has been elected as a new member of the U.S. National Academies Institute of Medicine (IO...

Douglas Oberhelman Elected to Lilly Board of Directors

INDIANAPOLIS, Oct. 20 /PRNewswire-FirstCall/ -- The Board of Directors of Eli Lilly and Company (NYSE: LLY ) has elected Douglas R. Oberhelman as a new member, effective December 1, 2008. Oberhelman, 55, currently serves as a group president of Caterpillar Inc. and is a member of Caterpillar'...

Barry Ginsberg, M.D., Ph.D. Elected to Biodel's Board of Directors

DANBURY, Conn., June 11 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Barry Ginsberg, M.D., Ph.D., has been elected as a new member of its Board of Directors, effective June 10, 2008. Dr. Ginsberg is currently Chief Executive Officer of Diabetes Technology Consultan...

Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors

SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that Lucy Shapiro, Ph.D., a renowned molecular microbiologist at Stanford University, has been elected to its board of directors. Gen-Probe's board now has eight members, including seven who are...

Thomas W. Burke, MD, Elected 40th President of the Society of Gynecologic Oncologists

CHICAGO, March 26 /PRNewswire/ -- Thomas W. Burke, MD, Executive Vice President and Physician-in-Chief at The University of Texas M.D. Anderson Cancer Center, has been elected the 40th President of the Society of Gynecologic Oncologists (SGO) at the organization's 39th Annual Meeting, held Mar...

USANA's CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporation's Board of Directors

LA JOLLA, Calif., March 17 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) is pleased to announce that Myron W. Wentz, Ph.D., Chief Executive Officer and Chairman of the Board of USANA Health Sciences, Incorporated (Nasdaq: USNA ), was elected to serve as a member o...

Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair

CLINTON, N.J., Jan. 22 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biopharmaceutical company, announced today that Lota S. Zoth has been elected as an independent member of the company's Board of Directors. Ms. Zoth, the former Chief Financial Officer of MedImmune, ...

Rothwell, Wolf Elected to Codexis Board

REDWOOD CITY, Calif., Dec. 12 /PRNewswire/ -- Codexis, Inc., a leading developer of clean technology manufacturing processes, today announced two new directors have been named to the company's Board of Directors. Joining the Board are Bill Rothwell, Ph.D., Vice President of Innovation and Chem...

Bruce Pasternack Elected to Codexis Board

REDWOOD CITY, Calif., Sept. 6 /PRNewswire/ -- Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced Bruce A. Pasternack has been elected to the company's Board of Directors. His election expands the Board to seven members. "Bruc...

Merges Simon Elected to DICOM Standards Committee

MILWAUKEE- Merge eFilm , a Wisconsin-based global healthcare software and services company, announced Wednesday that Dwight Simon, its medical standards director and senior integration specialist, has been elected as the Co-Chair of the Digital Imaging and Communications in Medicine (DICOM) Standa...

Madison bishop with stem-cell views elected to national ethics group

Madison Bishop Robert Morlino has been elected chairman of the board of the National Catholic Bioethics Center, which discusses issues such as stem-cell research. Morlino told The Capital Times in Madison that the destruction of a human embryo is always morally wrong, and that research on emb...

Tommy Thompson elected to board of Jersey medical firm

Madison, Wis. - Former Wisconsin Gov. and Secretary of Health and Human Services Tommy Thompson will join the board of directors at C.R. Bard , the company announced Tuesday. Thompson was elected to the post at the company's August board meeting. Bard, a healthcare technology firm headquarter...

Wisconsin professors elected to National Academy of Sciences

Madison, Wis . - University of Wisconsin-Madison faculty members Sean Carroll and Laura Kiessling are among 72 new fellows elected to the National Academy of Sciences . Election to the academy is considered one of the most prestigious honors bestowed upon American scientists. Carroll, a prof...

Novavax Reports Second Quarter 2009 Financial Results

...illion. The remaining $5.0 million in outstanding convertible notes matured on July 15, 2009. In accordance with the terms of the notes, the company elected to pay 50% of the principal plus accrued and unpaid interest, or $2.6 million, in cash and issued 1,016,939 shares of common stock to pay the remainin...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...Warrants will be used (i) to repay approximately $5.7 million in principal and unpaid accrued interest due to holders of the Old Notes that have not elected to participate in this financing transaction, (ii) to repay all remaining amounts (approximately $2.7 million), including certain prepayment fees, due...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

...-recognized interferon dependent biomarkers. Phase I Clinical Trial in Oncology. In order to focus its resources on ANA598, Anadys recently elected to stop enrollment of new patients in the ongoing Phase I oncology trial of ANA773. Anadys plans for currently enrolled patients to continue to recei...

Novavax Announces Repayment of $5 Million of Convertible Debt

...notes, at its option, Novavax could pay up to 50% of the notes in the company's common stock subject to the satisfying certain conditions. Novavax has elected to pay 50% of the principal plus accrued and unpaid interest in cash for a total payment of approximately $2.6 million and issued common stock for the...

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

...k will lead the company's business development activities. Dr. Corey Goodman, recently the president of Pfizer's Biotherapeutics and Bioinnovation, an elected member of the U.S. National Academy of Sciences, and a board member of iZumi, will become chairman of the Board of Directors of iPierian. The s...

Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.

...ed a Bachelor of Science in Plastics Engineering with a Biomaterials emphasis at the University of Massachusetts in 1980. In addition, Mr. Hobbs was elected to and currently serves on the Board of Directors of the Society of Interventional Radiology Foundation and as Vice Chairman of the Medical Device Man...

Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships

...rimarily to the Federal Government and city, state, and local agencies -- managing over half-a-million IT users daily. "We are honored that Rod elected to join the MicroTech Team," said Tony Jimenez, President and CEO of MicroTech. "His leadership, integrity, and commitment track perfectly with our ...

Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer

... --Dr. Sherman also elected President of the Drug Information Association (DIA)-- NORTHBROOK, Ill....ies." In addition to his Horizon appointment, Dr. Sherman was recently elected President of the Drug Information Association (DIA), a global, nonprofit, m...

OncoGenex Pharmaceuticals Files Shelf Registration Statement

..., we do not expect to offer at the present time securities under this shelf registration to fund our Phase 3 clinical trials for OGX-011." OncoGenex elected to terminate its previous shelf registration statement originally filed in July 2007. If declared effective by the SEC and the British Columbia Secu...

Paulo F. Costa Joins MacroGenics Board of Directors

... ROCKVILLE, Md., June 23 /PRNewswire/ -- MacroGenics, Inc. announced today that Mr. Paulo F. Costa has been elected to the company's Board as an independent director. Mr. Costa is the former President and Chief Executive Officer of Novartis U.S. Corporation. With ...

Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO

... announced the board of directors has appointed James M. Frincke Ph.D. as President and CEO of Hollis-Eden Pharmaceuticals, Inc. Dr. Frincke was also elected to the company's board of directors. Dr. Frincke joined Hollis-Eden as Vice President, Research and Development in 1997, was promoted to Executiv...

Guy J. Quigley Resigns as Chairman and CEO of The Quigley Corporation: Quigley Leaves Company He Founded 20 Years Ago

...om the years of work and patience on behalf of the resigning Board, and the stockholders of The Quigley Corporation. We remain hopeful that the newly elected Board will convert value from the table that has been set for them. To ensure the Company continues to function in the wake of the new Board's unknow...

iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

...itute, Evan Rauch Professor of Neuroscience, co-founder of the Wills Neuroscience Institute, and head of the Division of Neurobiology. Dr. Goodman was elected a member of the U.S. National Academy of Sciences, a fellow of the American Academy of Arts and Sciences, and a member of the American Philosophical S...

Sirius Genomics Announces 2009 Board of Directors

... VANCOUVER, June 8 /PRNewswire/ - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced that it has elected its 2009 Board of Directors at its recent Annual General Meeting. The six-member Board consists of: Dr. James McEwen (Chairman), Dr. Heiner Dreismann,...

Icahn Indicates That Biogen Board Refuses To Close Polls

...om winning seats on the Board. If the Board is successful, Richard Mulligan, a prominent scientist and physician, may be kept from legitimately being elected to the Board. This is a consistent theme of this Board. Do everything possible to keep shareholders from entering into the Board's private club to e...

Amylin Announces Preliminary Tabulation of Annual Meeting Results

...en Behrens and Dr. Alexander J. Denner, Director candidates nominated by Eastbourne Capital Management, L.L.C. and Carl Icahn, respectively, were also elected to the Board. Joseph C. Cook, Jr., Amylin's Chairman, and James N. Wilson, Amylin's Lead Independent Director, were not re-elected to the Board. ...

Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation

...ations used to compute Medicaid rebates for API products. Although the company believes API acted in accordance with the law at the time, the company elected to resolve this legacy matter through this settlement, without admitting any wrongdoing. The settlement calls for payment of $95.5 million (plus ...

Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices)

...Stem Cell Research (ISSCR). Dr. Grekos is also working with several members of Congress in promoting the Adult Stem cell Caucus to further educate our elected representatives on the safety and efficacy of adult stem cells. More information on Dr. Grekos can be found at Regenocyte . MEDIA CONTACT: Holl...

The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders

...mited business experience in the United States. With respect to Biovail's corporate governance standards, the Concerned Shareholders believe that if elected Mr. Haggis and Mr. Potter would satisfy these requirements relating to "interlock" board memberships as, if elected, they would only serve on the Boar...

deCODE genetics Announces First Quarter 2009 Financial Results

...tes interest payment. In order to provide more time for the execution of strategic alternatives currently under consideration, the company elected to utilize a 30-day grace period for the scheduled April 15 interest payment on its outstanding 3.5% Senior Convertible Notes due 2011. ...

PDL BioPharma Announces First Quarter 2009 Financial Results

... stockholders of record on such date as to be determined by the Board of Directors at its June 2009 meeting. Recent Developments -- elected Frederick Frank and Jody Lindell to the Company's Board of Directors in March 2009 and subsequently designated Mr. Frank as Lead Directo...

Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout

...ditional information contained in the submissions constituted major amendments. In an effort to include the amendments as part of the review, the FDA elected to extend the BLA review period and assigned a revised PDUFA date of August 1, 2009. ABOUT KRYSTEXXA(TM) KRYSTEXXA (TM) (pegloticase) is a p...

MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of State's Growing Awareness of Industry's Economic Importance

...d Ann Arbor-based Sensigen. During the Annual Meeting, MichBio members elected six board directors to three-year terms. elected to the board were J. Patrick Elliott, Vice President, Business Development ...